Monument Capital Management raised its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,880 shares of the semiconductor company’s stock after acquiring an additional 20 shares during the period. Monument Capital Management’s holdings in Synopsys were worth $1,074,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in SNPS. Mutual Advisors LLC boosted its holdings in shares of Synopsys by 3.1% during the third quarter. Mutual Advisors LLC now owns 855 shares of the semiconductor company’s stock worth $392,000 after acquiring an additional 26 shares during the period. Fred Alger Management LLC boosted its stake in shares of Synopsys by 1.8% in the third quarter. Fred Alger Management LLC now owns 1,150 shares of the semiconductor company’s stock valued at $528,000 after buying an additional 20 shares during the period. Gotham Asset Management LLC boosted its stake in shares of Synopsys by 35.9% in the third quarter. Gotham Asset Management LLC now owns 8,428 shares of the semiconductor company’s stock valued at $3,868,000 after buying an additional 2,227 shares during the period. Truist Financial Corp boosted its stake in shares of Synopsys by 119.2% in the third quarter. Truist Financial Corp now owns 27,626 shares of the semiconductor company’s stock valued at $12,680,000 after buying an additional 15,024 shares during the period. Finally, Advisors Asset Management Inc. boosted its stake in shares of Synopsys by 18.8% in the third quarter. Advisors Asset Management Inc. now owns 6,787 shares of the semiconductor company’s stock valued at $3,115,000 after buying an additional 1,072 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.1 %
Shares of NASDAQ:SNPS traded down $0.70 during trading on Wednesday, hitting $608.96. 205,603 shares of the company were exchanged, compared to its average volume of 1,085,493. The business’s 50 day moving average is $573.27 and its 200-day moving average is $557.04. The company has a market capitalization of $93.30 billion, a P/E ratio of 66.21, a price-to-earnings-growth ratio of 3.84 and a beta of 1.07. Synopsys, Inc. has a 1-year low of $418.51 and a 1-year high of $629.38.
Insider Transactions at Synopsys
In related news, CEO Sassine Ghazi sold 10,294 shares of the stock in a transaction on Friday, May 24th. The stock was sold at an average price of $582.41, for a total value of $5,995,328.54. Following the completion of the sale, the chief executive officer now directly owns 62,568 shares in the company, valued at $36,440,228.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Sassine Ghazi sold 10,294 shares of the stock in a transaction on Friday, May 24th. The stock was sold at an average price of $582.41, for a total value of $5,995,328.54. Following the completion of the sale, the chief executive officer now directly owns 62,568 shares in the company, valued at $36,440,228.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Geus Aart De sold 4,212 shares of the stock in a transaction on Tuesday, June 25th. The shares were sold at an average price of $600.05, for a total value of $2,527,410.60. Following the completion of the sale, the insider now owns 106,983 shares of the company’s stock, valued at $64,195,149.15. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 36,232 shares of company stock worth $21,436,741. Corporate insiders own 0.66% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the company. JPMorgan Chase & Co. boosted their price target on Synopsys from $650.00 to $655.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Piper Sandler reiterated an “overweight” rating and issued a $672.00 price target (up from $665.00) on shares of Synopsys in a research note on Thursday, May 23rd. Rosenblatt Securities reiterated a “buy” rating and issued a $615.00 price target on shares of Synopsys in a research note on Thursday, May 23rd. KeyCorp upped their target price on Synopsys from $675.00 to $690.00 and gave the stock an “overweight” rating in a research note on Thursday, June 27th. Finally, Robert W. Baird upped their target price on Synopsys from $645.00 to $661.00 and gave the stock an “outperform” rating in a research note on Tuesday. Eleven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $625.82.
Get Our Latest Stock Report on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Are Penny Stocks a Good Fit for Your Portfolio?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- What is a Bond Market Holiday? How to Invest and Trade
- GitLab Stock Rebounds: The Inside Story of Its Comeback
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is Rivian Stock on the Verge of a 100% Rally?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.